Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III

Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease (2021) Simon D, Tascilar K, Fagni F, Schmidt K, Krönke G, Kleyer A, Ramming A, et al. Journal article Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis (2021) O'Neil LJ, Hu P, Liu Q, Islam MM, Spicer V, Rech J, Hueber A, et al. Journal article Reframing immune-mediated inflammatory diseases (2021) Boutrid N, Rahmoune H, Schett G, McInnes I, Neurath M Journal article IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation (2021) Faas M, Ipseiz N, Ackermann J, Culemann S, Grüneboom A, Schröder F, Rothe T, et al. Journal article More on CD19-CAR T Cells in Systemic Lupus Erythematosus (2021) Mougiakakos D, Krönke G, Schett G Journal article, Letter Virtual teaching for medical students during SARS-CoV-2 pandemic (2021) Pfeil A, Franz M, Hoffmann T, Klemm P, Oelzner P, Muller-Ladner U, Lange U, et al. Journal article, Letter The role of IL-23 in joint disease (2021) Schett G Journal article, Editorial Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis (2021) Pournara E, Kormaksson M, Nash P, Ritchlin CT, Kirkham BW, Ligozio G, Pricop L, et al. Journal article Overexpression of transmembrane TNF drives development of ectopic lymphoid structures in the bone marrow and B cell lineage alterations in experimental spondyloarthritis (2021) Kaaij MH, Rip J, Jeucken KC, Kan YY, van Rooijen CC, Saris J, Pots D, et al. Journal article Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial (2021) Tascilar K, Hagen M, Kleyer A, Simon D, Reiser M, Hueber A, Manger B, et al. Journal article